18F-FDG PET/CT examination procedures may be optimized with improved patient information and care.
Web-based educational information regarding upcoming FDG-PET/CT scans can ease patient concern and improve experience, according to a study published in the Journal of Nuclear Medicine Technology.
Researchers from Sweden investigated the effect of web-based patient information on patient satisfaction with care during an 18F-FDG PET/CT examination, their knowledge about the examination and the image quality, compared with standard care, and to explore the usage of and satisfaction with web-based information.
A total of 148 patients participated in the trial. They were randomly assigned to Standard Care (SC) or an Intervention Group (IG). The patients in the SC received information about the 18F-FDG PET/CT examination according to standard care. Those in the IG also received access to web-based information about the examination. A questionnaire was used to evaluate patient satisfaction, knowledge and discomfort and a blinded image quality assessment was conducted.
The results showed that overall satisfaction was high in both the IG and SC, although only 54 of the 75 patients (72 percent) actually accessed the web-based information prior to their examination. The lowest satisfaction concerned the information about how the patients would receive the results about the PET/CT examination. More patients in IG than SC knew how the 18F-FDG PET/CT examination was conducted. Descriptive data suggest that image quality was slightly better in IG than SC, but there were no statistically significant differences between the groups regarding any of the outcomes.
The IG patients who did use the web-based information indicated they were satisfied and found it helpful.
The researchers concluded that the effects of web-based information need to be investigated in a larger sample of patients because improved information before an 18F-FDG PET/CT examination may increase patient knowledge and help them to prepare and undergo the examination. It may also improve image quality.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.